Evaluation of the intestinal microbiota and short-chain fatty acids content in patients with chronic inflammatory bowel diseases
Background. The pathogenesis of chronic inflammatory bowel disease (IBD) is still not fully clarified. It is known that disorders of the intestinal microbiota lead to an increased intestinal permeability, activation of mucous and adaptive immunity, impaired production and intestinal absorption of sh...
Main Authors: | M.V. Stoykevich, N.S. Fedorova, N.V. Nedzvetskaya, I.A. Klenina, O.M. Tatarchuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2021-06-01
|
Series: | Gastroenterologìa |
Subjects: | |
Online Access: | http://gastro.zaslavsky.com.ua/article/view/233631 |
Similar Items
-
Age-related and gender features of circulating immune complexes and lipid metabolism in inflammatory bowel diseases
by: M.V. Stoikevych, et al.
Published: (2019-02-01) -
Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
by: Marcello Candelli, et al.
Published: (2021-06-01) -
Application of 5-Aminosalicylic Acid Preparations in the Treatment of Inflammatory Bowel Diseases
by: Yu.M. Stepanov, et al.
Published: (2016-09-01) -
The microbiota in inflammatory bowel disease: current and therapeutic insights
by: Lane ER, et al.
Published: (2017-06-01) -
The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
by: Magdalena Stojek, et al.
Published: (2021-09-01)